Elevation Oncology (ELEV) Short Interest Ratio & Short Volume $0.61 -0.04 (-6.53%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.62 +0.02 (+2.57%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Elevation Oncology Short Interest DataElevation Oncology (ELEV) has a short interest of 8.77 million shares, representing 16.86% of the float (the number of shares available for trading by the public). This marks a -1.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 3.16 million shares to cover all short positions.Current Short Interest8,770,000 sharesPrevious Short Interest8,940,000 sharesChange Vs. Previous Month-1.90%Dollar Volume Sold Short$6.08 millionShort Interest Ratio4.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares59,120,000 sharesFloat Size52,020,000 sharesShort Percent of Float16.86%Today's Trading Volume922,491 sharesAverage Trading Volume3,156,658 sharesToday's Volume Vs. Average29% Short Selling Elevation Oncology? Sign up to receive the latest short interest report for Elevation Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELEV Short Interest Over TimeELEV Days to Cover Over TimeELEV Percentage of Float Shorted Over Time Elevation Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20258,770,000 shares $6.08 million -1.9%16.9%4.3 $0.69 1/15/20258,940,000 shares $6.51 million +38.8%17.2%4.6 $0.73 12/31/20246,440,000 shares $3.62 million +4.7%12.4%6.3 $0.56 12/15/20246,150,000 shares $3.91 million +0.3%11.8%7.9 $0.64 11/30/20246,130,000 shares $3.90 million +1.8%11.8%8.5 $0.64 11/15/20246,020,000 shares $3.20 million -3.1%11.6%8.6 $0.53 10/31/20246,210,000 shares $3.57 million +4.4%12.4%8.1 $0.57 10/15/20245,950,000 shares $3.09 million -3.3%11.9%5.1 $0.52 9/30/20246,150,000 shares $3.69 million -1.8%12.3%5.2 $0.60 9/15/20246,260,000 shares $3.81 million -4.7%12.5%4.7 $0.61 Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/31/20246,570,000 shares $5.11 million +2.7%13.1%5.1 $0.78 8/15/20246,400,000 shares $4.62 million -4.2%12.8%5 $0.72 7/31/20246,680,000 shares $17.57 million No Change13.8%5.8 $2.63 7/15/20246,680,000 shares $20.17 million +28.7%14.9%8.1 $3.02 6/30/20245,190,000 shares $14.01 million -2.1%10.8%6.9 $2.70 6/15/20245,300,000 shares $17.12 million -0.2%11.1%7.7 $3.23 5/31/20245,310,000 shares $21.35 million +3.9%11.3%7.7 $4.02 5/15/20245,110,000 shares $19.06 million +4.5%10.9%5.5 $3.73 4/30/20244,890,000 shares $17.36 million -1.2%11.5%4.9 $3.55 4/15/20244,950,000 shares $21.93 million -1.2%13.0%4.2 $4.43 3/31/20245,010,000 shares $25.70 million +8.2%12.6%1.6 $5.13 3/15/20244,630,000 shares $20.33 million +28.3%11.6%1.6 $4.39 2/29/20243,610,000 shares $15.92 million -10.0%9.1%1.3 $4.41 2/15/20244,010,000 shares $11.11 million +13.9%11.6%1.5 $2.77 1/31/20243,520,000 shares $9.79 million +95.6%10.1%1.4 $2.78 1/15/20241,800,000 shares $4.93 million +124.0%5.2%0.8 $2.74 12/31/2023803,700 shares $431,586.90 +21.0%2.5%0.5 $0.54 12/15/2023664,500 shares $338,961.45 +12.0%2.1%2.8 $0.51 11/30/2023593,500 shares $315,742.00 -10.8%1.8%2.7 $0.53 11/15/2023665,100 shares $307,276.20 -22.3%2.1%2.9 $0.46 10/31/2023856,100 shares $410,928.00 -8.2%2.8%4.1 $0.48 10/15/2023932,200 shares $616,184.20 +0.6%3.1%5.6 $0.66 9/30/2023926,500 shares $613,898.90 -24.7%3.1%4.9 $0.66 9/15/20231,230,000 shares $895,440.00 +1.7%4.1%5.5 $0.73 8/31/20231,210,000 shares $924,440.00 -4.7%5.2%2.6 $0.76 8/15/20231,270,000 shares $1.16 million +0.8%5.4%0.8 $0.91 7/31/20231,260,000 shares $1.51 million -4.6%4.7%0.7 $1.20 7/15/20231,320,000 shares $1.97 million -11.4%8.6%0.7 $1.49 6/30/20231,490,000 shares $2.26 million -4.5%9.8%0.8 $1.52 6/15/20231,560,000 shares $2.31 million -39.3%10.2%0.8 $1.48Buy this AI Stock Before Elon’s Announcement (Ad)With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.Click here to watch my presentation and learn how to invest today. 5/31/20232,570,000 shares $10.85 million +596.3%16.4%1.2 $4.22 5/15/2023369,100 shares $1.35 million -64.2%2.3%0.4 $3.67 4/30/20231,030,000 shares $2.71 million +688.7%6.7%1.3 $2.63 4/15/2023130,600 shares $254,670.00 +6.0%0.9%0.3 $1.95 3/31/2023123,200 shares $234,080.00 +135.6%0.8%0.2 $1.90 3/15/202352,300 shares $121,336.00 +28.2%0.3%0.1 $2.32 2/28/202340,800 shares $44,982.00 +22.5%0.3%0.4 $1.10 2/15/202333,300 shares $32,634.00 -18.2%0.2%0.4 $0.98 1/31/202340,700 shares $40,700.00 +20.8%0.3%0.5 $1.00 1/15/202333,700 shares $33,396.70 -29.4%0.2%0.4 $0.99 12/30/202247,700 shares $45,315.00 +10.7%0.3%0.7 $0.95 12/15/202243,100 shares $40,945.00 -2.1%0.3%1.1 $0.95 11/30/202244,000 shares $39,776.00 -10.4%0.3%1 $0.90 11/15/202249,100 shares $47,627.00 +6.1%0.3%1 $0.97 10/31/202246,300 shares $50,004.00 +42.5%0.3%0.9 $1.08 10/15/202232,500 shares $35,425.00 -62.7%0.2%0.5 $1.09 9/30/202287,200 shares $98,536.00 +76.5%0.6%1.1 $1.13 9/15/202249,400 shares $61,750.00 -12.6%0.3%0.5 $1.25 8/31/202256,500 shares $64,975.00 +61.4%0.4%0.4 $1.15 8/15/202235,000 shares $47,600.00 -38.1%0.2%0.1 $1.36 7/31/202256,500 shares $71,190.00 -13.5%0.4%0.1 $1.26 7/15/202265,300 shares $89,461.00 -92.8%0.5%0.1 $1.37 6/30/2022905,700 shares $1.27 million -1.1%6.5%1.5 $1.40 6/15/2022915,900 shares $1.24 million -18.2%6.6%1.5 $1.35 5/31/20221,120,000 shares $2.53 million +19.5%8.1%2 $2.26 5/15/2022937,000 shares $3.35 million +0.2%9.2%21.6 $3.57 4/30/2022935,600 shares $2.87 million +21.5%9.2%18.4 $3.07 4/15/2022770,300 shares $1.92 million +8.9%7.6%15.3 $2.49 3/31/2022707,300 shares $1.78 million +27.9%N/A14.1 $2.52 3/15/2022552,900 shares $1.39 million +4.5%5.4%9 $2.51 2/28/2022529,100 shares $1.79 million -0.2%5.2%6.9 $3.38 2/15/2022530,200 shares $2.15 million +619.4%5.2%7.1 $4.05 1/31/202273,700 shares $322,069.00 +12.5%0.6%1 $4.37 1/15/202265,500 shares $393,000.00 +2.8%N/A1.2 $6.00 12/31/202163,700 shares $383,474.00 -55.2%0.5%1.2 $6.02 12/15/2021142,200 shares $675,450.00 +20.1%1.0%3 $4.75 11/30/2021118,400 shares $776,313.28 +0.9%0.9%2.5 $6.56 11/15/2021117,400 shares $896,936.00 -7.3%0.8%3.2 $7.64 10/29/2021126,600 shares $1.05 million -8.4%0.9%3.2 $8.27 10/15/2021138,200 shares $1.10 million -0.4%1.0%3.1 $7.96 9/30/2021138,700 shares $1.08 million +4,234.4%1.0%2.7 $7.79 9/15/20213,200 shares $31,680.00 -79.6%0.0%0 $9.90 8/31/202115,700 shares $183,690.00 -17.8%0.1%0.1 $11.70 8/13/202119,100 shares $219,650.00 No Change0.2%0.2 $11.50 ELEV Short Interest - Frequently Asked Questions What is Elevation Oncology's current short interest? Short interest is the volume of Elevation Oncology shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 8,770,000 shares of ELEV short. 16.86% of Elevation Oncology's shares are currently sold short. Learn More on Elevation Oncology's current short interest. What is a good short interest ratio for Elevation Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELEV shares currently have a short interest ratio of 4.0. Learn More on Elevation Oncology's short interest ratio. Which institutional investors are shorting Elevation Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Elevation Oncology: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Elevation Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.86% of Elevation Oncology's floating shares are currently sold short. Is Elevation Oncology's short interest increasing or decreasing? Elevation Oncology saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 8,770,000 shares, a decrease of 1.9% from the previous total of 8,940,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Elevation Oncology's float size? Elevation Oncology currently has issued a total of 59,120,000 shares. Some of Elevation Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Elevation Oncology currently has a public float of 52,020,000 shares. How does Elevation Oncology's short interest compare to its competitors? 16.86% of Elevation Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elevation Oncology: Silence Therapeutics plc (4.34%), Zentalis Pharmaceuticals, Inc. (6.81%), Fate Therapeutics, Inc. (11.30%), ADC Therapeutics SA (5.03%), Sagimet Biosciences Inc. (24.13%), Solid Biosciences Inc. (8.09%), Puma Biotechnology, Inc. (8.53%), Biomea Fusion, Inc. (33.92%), Coherus BioSciences, Inc. (26.66%), Seres Therapeutics, Inc. (10.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Elevation Oncology stock? Short selling ELEV is an investing strategy that aims to generate trading profit from Elevation Oncology as its price is falling. ELEV shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elevation Oncology? A short squeeze for Elevation Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELEV, which in turn drives the price of the stock up even further. How often is Elevation Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELEV, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies SLN Short Interest Data ZNTL Short Interest Data FATE Short Interest Data ADCT Short Interest Data SGMT Short Interest Data SLDB Short Interest Data PBYI Short Interest Data BMEA Short Interest Data CHRS Short Interest Data MCRB Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELEV) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
